Global Hemp Group Inc (GBHPF)

[Lloyd Cannabinoid]

UPDATE: Five reasons to buy cannabis stocks after a punishing rout
Today 4:33 AM ET (MarketWatch)
Share
Print


By Michael Brush, MarketWatch
There's potential good news ahead, which could quickly change sentiment in the marijuana industry
Cannabis stocks have sent investors on a wild ride in the past year.
Shares in the burgeoning industry had halved by the end of August compared with a year earlier, when they were pushed higher by bullish sentiment. Canopy Growth (WEED.T) and Tilray (TLRY), two bellwethers, had plummeted even more -- by 54% and 64%, respectively. The popular ETFMG Alternative Harvest exchange traded fund (MJ) had fallen 45%.
But cannabis investors, take heart. Cannabis stocks are about to get higher valuations. That's because the selling became so extreme last month, marijuana stocks hit capitulation lows Aug. 28, the Bear Traps Report's (https://www.thebeartrapsreport.com) Larry McDonald wrote on that day.
He suggested investors take opening, one-third positions in the ETFMG Alternative Harvest ETF as a contrarian bet on the group. McDonald made a good call, even if he stopped short of saying go all in. Since then, cannabis stocks have rallied nicely.
But they have more to go. Capitulation lows are blow-off events in which most of the losers and weak hands finally throw in the towel. As such, they can punctuate a bottom by clearing the negativity, and serve as the starting point for a sentiment reset. All the bad news -- and there is plenty of it -- seems to be priced in. Yet several catalysts loom. They will continue to fire up sentiment.
Cannabis stocks do not have the insider buying I normally like to have on my side, but they're disliked enough to give them the out-of-favor contrarian profile I like to see to put names in my stock letter, Brush Up on Stocks (http://www.uponstocks.com).
Here's a look at what's gone wrong -- and what could go right -- to continue driving marijuana stocks higher, even if it won't be straight up.
Catalyst No. 1: Branded edibles begin to take off in Canada
A big knock on cannabis companies is that weed is a boring commodity, much like corn or wheat. This is such a common gripe, it's a mere cliché by now. But publicly traded cannabis suppliers do need to break out of commodity jail. To do so, they have to learn how to be to marijuana what Coca-Cola (KO) and Pepsi (PEP) are to sugar water. They have to develop powerful brands in higher-margin derivative products such as edibles, vapes and drinks that consumers love.
They're about to get their first big shot on goal in Canada, which has been paving new ground in legalized cannabis.
Until recently, Canada had only approved the sale of bud, oils (tinctures) and gel caps. Now that's changed. Canada recently cleared the way for legal edible products, vapes and cannabis drinks. They will start hitting the shelves in December. This development -- and the buildup to it between now and then -- will generate a lot of buzz among cannabis investors, and shift the sentiment needle back toward bullish. That will push cannabis stocks higher between now and year-end, and beyond.
"We will see a slew of new products hitting the market," says Korey Bauer, portfolio manager of the Cannabis Growth Fund . "We think this is going to be massive for these companies."
"I'm personally really excited about edibles legalization in Canada," says Motley Fool investment analyst Emily Flippen, who studies the cannabis space. She says it will give companies the chance to sell higher-margin products, and shake off their commodity status. The edibles and vape breakthrough will also broaden the appeal of cannabis among consumers.
To understand why, consider how popular these products are in the U.S. market. Derivative cannabis products -- as opposed to plain old bud -- account for roughly 60% of sales in the legal U.S. markets and a disproportionate percentage of growth, says Stifel analyst W. Andrew Carter.
In a follow up column on cannabis names, I'll present the companies most likely to benefit from the changes in Canada and the all-important brand development opportunity coming down the tracks as a result.
Catalyst No. 2: Trump (potentially) comes to the rescue
Political analysts claim to be unsure about President Donald Trump's views on cannabis. But there are plenty of signs that Trump doesn't have the typical New Yorker's "live and let live" outlook. He hired (and then fired) an attorney general who vowed to enforce federal prohibition of cannabis. Surgeon General Jerome Adams just published a scathing report on the very real health risks of weed, which I have also written about (http://www.marketwatch.com/story/marijuana-investors-are-forgetting-about-legal-risks-faced-by-cannabis-companies-2019-04-23). Trump himself is donating part of his salary, about $100,000, to fund a media campaign on marijuana risks.
At the same time, though, Trump loves being president. So he is going to do what it takes to stay in office. That may mean a quick reversal on marijuana. Democratic presidential candidates are tripping over themselves to endorse progressive views on weed legalization. It would be just like Trump to undercut them by deciding to work toward legalization, or endorse states rights on the issue. Such a high-profile tactical move by our teetotaler president would boost sentiment on cannabis stocks, driving them higher.
Catalyst No. 3: Companies get more venues to sell their wares
Marijuana smokers love their bud tenders. "People really like to go to stores and see the product and talk about what it does," says Bauer at the Cannabis Growth mutual fund. "It is crucial for these stores to educate people on what they are buying."
In other words, the number of stores is key to sales, and it turns out there aren't enough of them in Canada. But that will soon change. Canada has recently conducted lotteries to license stores to developers. "The store shortage is going to be corrected," says Bauer. "We think this is going to be absolutely huge in the next 24 months. As more stores roll out, this will be a tail wind for licensed producers."
The Canadian market is the key piece of the puzzle here because virtually all of the publicly traded cannabis suppliers are based in Canada, selling into that market. They are loathe to sell in U.S. markets since that would violate U.S. law, which could get them kicked off their stock exchanges.
Catalyst No. 4: Less Sturm und Drang for the industry
A big reason why marijuana stocks have been weak is the perfect storm of disasters that hit this summer. It's been enough to put the enthusiasm of the most ardent bull in couch lock -- and that's exactly what happened.
-- The supplier CannTrust was caught growing in illegal labs. That helped push the stock down to $2 from $12 a year ago. A lot of investor wealth and enthusiasm got burned in the process. "It really shook confidence in the sector because they were considered safe and vetted," says Todd Harrison, the chief investment officer at CB1 Capital, which invests in the industry.
-- Suppliers Canopy Growth, Tilray and HEXO (HEXO.T) all reported lousy quarterly results. So did Charlotte's Web , which sells cannabidiol (CBD) for purported medical use.
-- Canopy's board kicked out CEO and marijuana-sector apostle Bruce Linton in a surprise move that shook a lot of investors.
-- Quebec announced tight restrictions on edibles based on concerns they might appeal too much to children.
In short, investors got rattled. That's a bunch of bad stuff at once, and in a kind of mean reversion to the norm, a stretch of time without a lot of disasters will heal the wounds, and boost sentiment toward the group.
Catalyst No. 5: Investors get clarity on the regulatory front
The cannabis sector is a regulatory briar patch. In the U.S., the drug is illegal at the federal level but increasingly legal among states. The FDA discourages CBD-infused products, yet they continue to be readily sold and openly promoted on Facebook (FB) and Twitter (TWTR), complete with exaggerated and false claims of medical efficacy. Canada legalized derivative products, but Quebec said "not so fast" to sweets that would appeal to children.
Progress toward regulatory clarity in any of these areas will reassure investors and boost enthusiasm toward cannabis stocks.
In the U.S., a proposed Secure and Fair Enforcement (SAFE) Banking Act would let banks legally get involved in the sector. A proposed Strengthening the Tenth Amendment Through Entrusting States (STATES) Act would recognize the legalization of cannabis in states. No one expects those bills to be approved soon. "But as long as they are moving in the right direction, the market will see this as a positive catalyst," says Bauer.
As for Quebec, Flippen at the Motley Fool thinks the province might not harsh on sweetened edibles as much as a lot of investors believe. "I think it is all going to come down to packaging," she says. "Quebec may allow edibles that are sweet, but packaged in way that does not appeal to children."
Then there's the Big Lebowski of breakthroughs in weed regulation -- legalization at the federal level.
"It's not a matter of if, but when, the federal government legalizes," says Flippen. Former Republican House Speaker John Boehner, who is on the board of the cannabis company Acreage Holdings , "continues to say that representatives are coming around to legalization," says Flippen. He sees legalization or decriminalization on the federal level by 2020 or 2021.
Progress here would really light up the group.
At the time of publication, Michael Brush had no positions in any stocks mentioned in this column. Brush is a Manhattan-based financial writer who publishes the stock newsletter, Brush Up on Stocks (http://www.uponstocks.com). Brush has covered business for the New York Times and The Economist Group, and he attended Columbia Business School in the Knight-Bagehot program.
-Michael Brush; 415-439-6400; [e-mail]

(END) Dow Jones Newswires
September 10, 2019 04:33 ET (08:33 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.

[Lloyd Cannabinoid]

UPDATE: Five reasons to buy cannabis stocks after a punishing rout
Today 4:33 AM ET (MarketWatch)
Share
Print


By Michael Brush, MarketWatch
There's potential good news ahead, which could quickly change sentiment in the marijuana industry
Cannabis stocks have sent investors on a wild ride in the past year.
Shares in the burgeoning industry had halved by the end of August compared with a year earlier, when they were pushed higher by bullish sentiment. Canopy Growth (WEED.T) and Tilray (TLRY), two bellwethers, had plummeted even more -- by 54% and 64%, respectively. The popular ETFMG Alternative Harvest exchange traded fund (MJ) had fallen 45%.
But cannabis investors, take heart. Cannabis stocks are about to get higher valuations. That's because the selling became so extreme last month, marijuana stocks hit capitulation lows Aug. 28, the Bear Traps Report's (https://www.thebeartrapsreport.com) Larry McDonald wrote on that day.
He suggested investors take opening, one-third positions in the ETFMG Alternative Harvest ETF as a contrarian bet on the group. McDonald made a good call, even if he stopped short of saying go all in. Since then, cannabis stocks have rallied nicely.
But they have more to go. Capitulation lows are blow-off events in which most of the losers and weak hands finally throw in the towel. As such, they can punctuate a bottom by clearing the negativity, and serve as the starting point for a sentiment reset. All the bad news -- and there is plenty of it -- seems to be priced in. Yet several catalysts loom. They will continue to fire up sentiment.
Cannabis stocks do not have the insider buying I normally like to have on my side, but they're disliked enough to give them the out-of-favor contrarian profile I like to see to put names in my stock letter, Brush Up on Stocks (http://www.uponstocks.com).
Here's a look at what's gone wrong -- and what could go right -- to continue driving marijuana stocks higher, even if it won't be straight up.
Catalyst No. 1: Branded edibles begin to take off in Canada
A big knock on cannabis companies is that weed is a boring commodity, much like corn or wheat. This is such a common gripe, it's a mere cliché by now. But publicly traded cannabis suppliers do need to break out of commodity jail. To do so, they have to learn how to be to marijuana what Coca-Cola (KO) and Pepsi (PEP) are to sugar water. They have to develop powerful brands in higher-margin derivative products such as edibles, vapes and drinks that consumers love.
They're about to get their first big shot on goal in Canada, which has been paving new ground in legalized cannabis.
Until recently, Canada had only approved the sale of bud, oils (tinctures) and gel caps. Now that's changed. Canada recently cleared the way for legal edible products, vapes and cannabis drinks. They will start hitting the shelves in December. This development -- and the buildup to it between now and then -- will generate a lot of buzz among cannabis investors, and shift the sentiment needle back toward bullish. That will push cannabis stocks higher between now and year-end, and beyond.
"We will see a slew of new products hitting the market," says Korey Bauer, portfolio manager of the Cannabis Growth Fund . "We think this is going to be massive for these companies."
"I'm personally really excited about edibles legalization in Canada," says Motley Fool investment analyst Emily Flippen, who studies the cannabis space. She says it will give companies the chance to sell higher-margin products, and shake off their commodity status. The edibles and vape breakthrough will also broaden the appeal of cannabis among consumers.
To understand why, consider how popular these products are in the U.S. market. Derivative cannabis products -- as opposed to plain old bud -- account for roughly 60% of sales in the legal U.S. markets and a disproportionate percentage of growth, says Stifel analyst W. Andrew Carter.
In a follow up column on cannabis names, I'll present the companies most likely to benefit from the changes in Canada and the all-important brand development opportunity coming down the tracks as a result.
Catalyst No. 2: Trump (potentially) comes to the rescue
Political analysts claim to be unsure about President Donald Trump's views on cannabis. But there are plenty of signs that Trump doesn't have the typical New Yorker's "live and let live" outlook. He hired (and then fired) an attorney general who vowed to enforce federal prohibition of cannabis. Surgeon General Jerome Adams just published a scathing report on the very real health risks of weed, which I have also written about (http://www.marketwatch.com/story/marijuana-investors-are-forgetting-about-legal-risks-faced-by-cannabis-companies-2019-04-23). Trump himself is donating part of his salary, about $100,000, to fund a media campaign on marijuana risks.
At the same time, though, Trump loves being president. So he is going to do what it takes to stay in office. That may mean a quick reversal on marijuana. Democratic presidential candidates are tripping over themselves to endorse progressive views on weed legalization. It would be just like Trump to undercut them by deciding to work toward legalization, or endorse states rights on the issue. Such a high-profile tactical move by our teetotaler president would boost sentiment on cannabis stocks, driving them higher.
Catalyst No. 3: Companies get more venues to sell their wares
Marijuana smokers love their bud tenders. "People really like to go to stores and see the product and talk about what it does," says Bauer at the Cannabis Growth mutual fund. "It is crucial for these stores to educate people on what they are buying."
In other words, the number of stores is key to sales, and it turns out there aren't enough of them in Canada. But that will soon change. Canada has recently conducted lotteries to license stores to developers. "The store shortage is going to be corrected," says Bauer. "We think this is going to be absolutely huge in the next 24 months. As more stores roll out, this will be a tail wind for licensed producers."
The Canadian market is the key piece of the puzzle here because virtually all of the publicly traded cannabis suppliers are based in Canada, selling into that market. They are loathe to sell in U.S. markets since that would violate U.S. law, which could get them kicked off their stock exchanges.
Catalyst No. 4: Less Sturm und Drang for the industry
A big reason why marijuana stocks have been weak is the perfect storm of disasters that hit this summer. It's been enough to put the enthusiasm of the most ardent bull in couch lock -- and that's exactly what happened.
-- The supplier CannTrust was caught growing in illegal labs. That helped push the stock down to $2 from $12 a year ago. A lot of investor wealth and enthusiasm got burned in the process. "It really shook confidence in the sector because they were considered safe and vetted," says Todd Harrison, the chief investment officer at CB1 Capital, which invests in the industry.
-- Suppliers Canopy Growth, Tilray and HEXO (HEXO.T) all reported lousy quarterly results. So did Charlotte's Web , which sells cannabidiol (CBD) for purported medical use.
-- Canopy's board kicked out CEO and marijuana-sector apostle Bruce Linton in a surprise move that shook a lot of investors.
-- Quebec announced tight restrictions on edibles based on concerns they might appeal too much to children.
In short, investors got rattled. That's a bunch of bad stuff at once, and in a kind of mean reversion to the norm, a stretch of time without a lot of disasters will heal the wounds, and boost sentiment toward the group.
Catalyst No. 5: Investors get clarity on the regulatory front
The cannabis sector is a regulatory briar patch. In the U.S., the drug is illegal at the federal level but increasingly legal among states. The FDA discourages CBD-infused products, yet they continue to be readily sold and openly promoted on Facebook (FB) and Twitter (TWTR), complete with exaggerated and false claims of medical efficacy. Canada legalized derivative products, but Quebec said "not so fast" to sweets that would appeal to children.
Progress toward regulatory clarity in any of these areas will reassure investors and boost enthusiasm toward cannabis stocks.
In the U.S., a proposed Secure and Fair Enforcement (SAFE) Banking Act would let banks legally get involved in the sector. A proposed Strengthening the Tenth Amendment Through Entrusting States (STATES) Act would recognize the legalization of cannabis in states. No one expects those bills to be approved soon. "But as long as they are moving in the right direction, the market will see this as a positive catalyst," says Bauer.
As for Quebec, Flippen at the Motley Fool thinks the province might not harsh on sweetened edibles as much as a lot of investors believe. "I think it is all going to come down to packaging," she says. "Quebec may allow edibles that are sweet, but packaged in way that does not appeal to children."
Then there's the Big Lebowski of breakthroughs in weed regulation -- legalization at the federal level.
"It's not a matter of if, but when, the federal government legalizes," says Flippen. Former Republican House Speaker John Boehner, who is on the board of the cannabis company Acreage Holdings , "continues to say that representatives are coming around to legalization," says Flippen. He sees legalization or decriminalization on the federal level by 2020 or 2021.
Progress here would really light up the group.
At the time of publication, Michael Brush had no positions in any stocks mentioned in this column. Brush is a Manhattan-based financial writer who publishes the stock newsletter, Brush Up on Stocks (http://www.uponstocks.com). Brush has covered business for the New York Times and The Economist Group, and he attended Columbia Business School in the Knight-Bagehot program.
-Michael Brush; 415-439-6400; [e-mail]

(END) Dow Jones Newswires
September 10, 2019 04:33 ET (08:33 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.

[Lloyd Cannabinoid]

It was trading at the .04 - .05 channel consistently. now the .03 -.04 channel today. I am debating adding shares in this channel.

[Lloyd Cannabinoid]

Why the Future of Marijuana Stocks Is American, Not Canadian, According to an Analyst -- Barrons.com
8/30/19 10:55 AM ET (Dow Jones)Print

Why the Future of Marijuana Stocks Is American, Not Canadian, According to an Analyst -- Barrons.com


By Bill Alpert
Rob Fagan is one of the few analysts anywhere who covers the stocks of U.S. cannabis chains like Green Thumb Industries or Curaleaf Holdings. The 39-year-old researcher at Canada's GMP Securities believes that the U.S. operators have better growth prospects than their better-known counterparts in Canada, like Canopy Growth. But even after this year's selloff of Canadian producers, U.S. weed operations sell for a fraction of the Canadians' multiples. Fagan explains why he thinks the U.S. stocks will take investors higher. An edited version of our conversation follows.
Barron's: How did a nice Canadian boy end up covering cannabis?
Fagan: I got a job at GMP Securities in 2011, working as a research associate for the consumer products analyst, Martin Landry. We were introduced to Canopy Growth (ticker: CGC) and led their public offering. They had a hard time just getting a meeting with other investment banks, but GMP goes after niches where they can have a good market share. Cannabis was one of them.
When we were marketing, Martin would say he didn't want to be the pot guy. But I said, "I always wanted to be the pot guy!" I'm a big fan of cannabis. It's something I'm passionate about. And I have a certain knowledge base that could give me a competitive edge.
Knowledge base?
Experience base...I don't know how else you would like me to describe it. An eye for quality, perhaps?
You focus on the U.S. multistate operators, instead of Canadian producers like Canopy or Aurora Cannabis (ACB). Why?
To be super honest, it just was a greenfield opportunity, where there was less competition for an up-and-comer like myself.
It's true that very few analysts cover U.S. operators. And they are Canadian stocks. Why?
Because of the federal illegality of cannabis in the U.S., these operations have not been able to list their securities on federally-regulated U.S. exchanges. One of the smaller exchanges in Canada -- the Canadian Securities Exchange -- did let them sell stock. It was the only place that these U.S. companies could access public markets, although they've since cross-listed on the OTC [over-the-counter] market in the U.S.
How can a U.S. resident go about buying one of these stocks?
The easiest way is to have a brokerage account that can access the OTC Markets Group in the U.S., or the Canadian Securities Exchange. Last I checked, there were a handful of self-directed brokers that could access the Canadian Securities Exchange for U.S. residents. But it's broadening out. There's now an ETF listed on the NYSE, the AdvisorShares Pure Cannabis exchange-traded fund (YOLO) that has exposure to the U.S. multistate operators through an equity swap arrangement.
Are stocks of these U.S. operators underpriced?
I strongly believe so. Just compare the market capitalizations of the U.S. and Canadian pot sectors, and the sales opportunity of each.
What are those numbers?
For most of Canada's licensed producers, you've got an aggregate market cap of 50 billion Canadian dollars [$31 billion], even after the group's selloff. They have a C$5 billion sales opportunity in Canada that they can readily address in the next few years. So that is a price-to-sales multiple of 10 times.
The U.S. operators have a market cap of $20 to $25 billion. Counting only the states that already have some form of medical or recreational access, their sales opportunity is around $22 billion within the next three to four years. So that's one-times sales.
Not only is the U.S. a larger opportunity, but it has a better economic model. In most states, you're allowed to go direct to your customer -- from production right up to retail -- cashing in on more of the value chain. There are also fewer restrictions on product forms and advertising than in Canada.
When will more states approve recreational sales?
In 2020, you might have an Arizona ballot initiative, a Florida ballot initiative. Connecticut has a chance of passing legalization. Maryland and Pennsylvania, too. New Jersey couldn't get enough votes in the legislature, but they will try again. That will put pressure on New York.
Read more: Marijuana Company Harvest Health Is Bullish on a Legalization Vote in Arizona
The markets where these companies operate are fantastic. Massachusetts converted from medical to recreational sales and is growing above a 500% annualized clip right now. Even a mature market like Arizona is still growing at a better than 30% annual rate.
Which of the U.S. operators interest you?
Green Thumb Industries (GTII.Canada or GTBIF). It is one of the best operators. They get things done, quickly and efficiently. They expanded their footprint across 10 states, while generating positive Ebitda [earnings before interest, taxes, depreciation, and amortization]. That's much better than many Canadian operators, some of whom have large Ebitda losses every quarter.
And they are known for having high product quality. Their product was tested by High Times magazine -- an authority in the space -- and certain of Green Thumb's proprietary strains tested at a total THC level of 38%. It was the most potent cannabis strain ever tested by High Times. That product is in such high demand in Massachusetts that some stores limit your purchase quantities.
How do you value Green Thumb?
I project the companies' revenues and Ebitda. Not too far in the future -- I use a 2020 estimate. Then I apply a fair multiple. In the case of Green Thumb, it's 20 times Ebitda.
Yikes!
Yes, that could be considered elevated. But there are factors that argue for a strong valuation multiple on a U.S. cannabis stock. There's the huge market growth opportunity from disrupting other consumer categories like alcohol. Another area where cannabis can be very disruptive is in treating opioid addiction.
OK. What Ebitda do you project for Green Thumb?
I estimate the company will generate $485 million of revenues next year, from organic growth and already-announced acquisitions. The company can go from a 13% Ebitda margin now to a 35% margin and $172 million in 2020 -- driven by what I expect will be scale benefits and vertical integration. I also include some contribution from future M&A.
So that's how you get to your target price of $24, for this $9 stock. Can they earn 35% Ebitda margins?
The benchmark for fully-integrated cannabis businesses is a company called Trulieve Cannabis (TRUL.Canada or TCNNF). It operates almost exclusively in Florida, where vertical integration is mandated. Trulieve just reported a quarter with 55% Ebitda margins.
So you like Trulieve?
Yes, that's another favorite. It was one of the first companies to open dispensaries in Florida in 2016, so it had almost 90% market share. Even after competitors have opened over 100 stores, Trulieve still has more than a 50% share on a dollar basis.
Does Trulieve operate outside of Florida?
They have acquired the holder of a provisional license in Massachusetts, where they plan to open three stores in the recreational channel. Given the kind of growth coming from the Massachusetts recreational market, it's going to be a nice state for Trulieve. They've also got a small footprint in Connecticut and a retail store in California.
Trulieve's last quarterly results were incredibly strong. I forecast $400 million in revenue for 2020. They've not gotten a fair valuation. The stock is trading below 6 times their 2020 Ebitda of $146 million; other large players are 9 to 11 times. The stock is $8 today. My target for Trulieve is $22.50, using a 17 1/2 multiple.
Who else do you like?
I would direct you to Curaleaf Holdings (CURA.Canada or CURLF). After some recent M&A, Curaleaf is by far the largest player in the U.S. cannabis industry. This year alone they deployed $2 billion on a number of transactions. They are under contract to acquire a company called Cura Partners, which manufacturers the Select brand of vaporization products -- it's the biggest-selling vape brand in California, Nevada, Arizona and Oregon. They have the potential to be a huge vertically-integrated player that can spread its products across the entire nation.
Curaleaf could exceed $1.1 billion in revenue next year, with a 34% Ebitda margin generating $390 million. That gets me to an $18 target for a stock that sells below $7 today.
Got another?
I would call out Cresco Labs (CL.Canada or CRLBF). It's a mix of retail and wholesale, and will be an interesting way to play California once it completes its acquisition of one of the largest distributors in the state -- a business called Origin House.
Like Green Thumb, Cresco was started in the Midwest and has solid platforms in Illinois and Pennsylvania. Cresco did a series of acquisitions at the end of last year, to get a national presence. Origin House touches nearly all the retail outlets in California. That compliments Cresco's earlier acquisition of a large wholesale cultivation operation there. They also have some pending M&A in Massachusetts, Florida, and New York.
Leading to sales and Ebitda of what?
We think Cresco Labs can generate in the area of $735 million in revenue next year. We assume an Ebitda margin of 34%, generating about $250 million of Ebitda. Our target price for this $8.25 stock is $16.
Anyone else you like?
Valuations are very attractive, so it is hard to not be positive. Another notable name is Harvest Health & Recreation (HARV.Canada or HRVSF). They hope to be one of the biggest in the industry. They are the leading participant in the Arizona market, which is only medical, but generates about $550 million of industry sales from a population of just seven million. Roughly 3% of the Arizona population uses medical cannabis, compared to a national average of about 1%.
(MORE TO FOLLOW) Dow Jones Newswires
August 30, 2019 10:55 ET (14:55 GMT)

[Lloyd Cannabinoid]

Dow rises over 300 points as China tamps down fears of trade-war escalation

[Lloyd Cannabinoid]

Definitely legit. Did some DD. I like it!

[Lloyd Cannabinoid]

Is this company legit? seems like nothing is going on.

[BigNexEnd]

I Agree. This Company Is Legit, And Slowly_Growing_The_Business...EOM

[Stock Prophet]

Thanks BigNexEnd! As I said, this company looks like one you want to board on. First class, or regular coach! Don't matter! Lol! I like where press releases are given to investors as soon as available. Communication is a vital key of making a company successful. Even with negative news. It shows concern and involvement with investors on the part of the company investors are putting their money into! Just saying!

[BigNexEnd]

NEWS!..Global Hemp Group Provides Revenue Update...

Vancouver, BC -- (August 9, 2019) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) is pleased toannounce that its JV subsidiary Covered Bridge Acres Ltd. (CBA) has begun generating revenue through operations at its hemp farm in Scio, Oregon.

Through a combination of the sales of raw biomass, plantlets, CBD crude oil and CBD distillate that was produced from various processing test runs, along with other farm operations, revenue generated to date by CBA in its first year of operations is US$525,500 (approx. CDN$695,000).

The most recent transaction, the sale of 10,000 lbs of shucked biomass, was sold to an Oregon extraction facility for US$400,000 (approx. CDN$530,000). The CBA team is currently working with this party and a number of others to complete the purchase of the remaining inventory.

Originally CBA was expecting to monetize the 2018 hemp biomass after entering into a processing agreement with Richardson Gap Farm LLC (RGF), as announced on May 18, 2019. RGF has been unable to process the agreed upon quantities of CBA’s biomass due to unforeseen issues with their processing equipment. Although RGF produces high quality distillate, CBA was no longer willing to delay the monetization of its biomass any further and decided to sell the biomass to another extractor. With multiple offers on the table to purchase the biomass, CBA shucked the biomass (removed stalks and stems) and completed the sale.



CBA still has approximately 4,000 lb of unshucked biomass out for processing into distillate by additional extractors and will split the final product on a 50/50 basis. Once processed, it will be sold along with inventory on hand (8 kg of 92% distillate that was processed by RGF from crude oil CBA received from other processors test runs). Recent sales of this type of distillate has been in the $4,000 per kg range.

Innovation and mechanization are keys to reducing labour costs on the farm. In preparation for the handling of this year’s harvest, the CBA team has designed a shucking machine to remove the flowers and leaves from the stalk and stems. They are in the process of fabricating a prototype and have reserved a small amount of biomass to test the equipment. Once shucked, the biomass will be processed into distillate for sale on the open market later this summer.

2019 Cultivation at the Scio Oregon Farm
A significantly larger quantity of biomass is expected from this year’s harvest as compared to the previous year, due to improved genetics, a longer growing season with earlier planting, and more plants in the ground. This year, the CBA team planted approximately 22% more plants at the farm (49,000 plants compared to only 40,000 in 2018). With the late start in 2018 due to timing of the farm acquisition, CBA’s access to higher quality genetics was limited. As a result, approximately 4,000 male plants were required to be culled from the field, netting approximately 36,000 plants at harvest. With improved, more stable genetics this year, the number of male plants that will be required to be culled from the field should greatly be reduced. In addition, cultivars planted this year are expected to produce a higher CBD yield from improved genetics.

In addition, incentive stock options have been granted to Directors, Officers and Consultants of the Company to purchase up to an aggregate 5,750,000 common shares of the Company, pursuant to the terms of the Company's stock option plan as approved by the shareholders on April 26, 2019. The stock options are exercisable at a price of $0.06 per share for a period of a five (5) years.

Instagram
Follow the development of the Scio Oregon Hemp Project on Instagram @hemp_global

About Global Hemp Group Inc.
Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FRANKFURT: GHG), is focused on a multi-phased strategy to build a strong presence in the industrial hemp industry in both Canada and the United States. The Company is headquartered in Vancouver, British Columbia, with hemp cultivation operations in New Brunswick and Oregon. The first phase of this strategy is to develop hemp cultivation with the objective of extracting cannabinoids (CBD, CBG, CBN & CBC) and creating a near term revenue stream that will allow the Company to expand and develop successive phases of the strategy. The second phase of the plan will focus on the development of value-added industrial hemp products utilizing the processing of the whole hemp plant, as envisioned in the Company’s Hemp Agro-Industrial Zone (HAIZ) strategy.

[Stock Prophet]

Nice article! I see this company going far with its business venture! That is why I am on board! I not real found of heights! But we going high and I will just have to hang on for the ride! Lol!

[BigNexEnd]

Global Hemp Group's Partner Page...Interesting Stuff...

https://www.qworxideas.com/

[BigNexEnd]

NEWS!..Global Hemp Group has Entered into a Technology Development Contract to Develop the World’s First Hemp Biocomposite Drone for Commercial Agricultural Monitoring

https://www.globalhempgroup.com/07182019global-hemp-group-has-entered-into-a-technology

Vancouver, BC -- (July 18, 2019) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) is pleased to announce that it has entered into a Technology Development Agreement with Q Worx LLC (“QWorx”) to develop the world’s first commercial hemp biocomposite (H-Fiber) drone specifically designed to monitor large scale cultivations, initially focusing on hemp. All on-field beta testing of the drone will be conducted at the Company’s JV hemp farm in Scio, Oregon.

Qworx, in association with FPV Militia, has developed a line of H-Fiber First Person View drones for competitive racing, freestyle and cinematic use. The agreement, for the development of an agricultural monitoring drone dubbed the “Field Agent”, is for a next generation drone that will be capable of monitoring various aspects of hemp cultivation on the farm.

The Field Agent is being constructed out of industrial hemp composites, making this drone stronger than similar models currently on the market made out of carbon fibre. It is non-conductive, made from renewable source materials, and has improved end of use recyclability. In addition, due to the nature of carbon fiber conductance, carbon fiber itself causes major radio frequency interference which can lead to signal degradation and drop out, which can lead to GPS satellite loss, as well as loss in video quality. Using hemp composites have completely eliminated these issues resulting in a far superior flight. The drone will be complete with a custom software platform which will enable the user to preprogram exact flight paths, altitudes and missions, allowing the user to fully automate the drone.

The Field Agent will reduce labour costs as it will reduce the need for team members to walk the field to monitor each plant for sufficient water, nutrients and to identify male plants that need to be culled. The Field Agent will be equipped with multiple cameras to identify potential disease and will connect to sensors strategically placed throughout the field to collect water saturation, soil temperature, nutrient content, among other data. API’s are being developed to interface with Agri-Analytics systems to collect and analyze data that can be used to optimize crop production.

Further research with the Field Agent project will be to identify male plants and hermaphrodites that must be culled prior to pollination of the female plants, so as to maintain the highest level of cannabinoid production from the plants, with the ultimate goal of using the drone to also cull the male plants once identified.

QWorx expects to have a working prototype ready to begin beta testing within in 30 to 45 days. Upon successful completion of the on-farm testing, GHG and QWorx will explore manufacturing and marketing of the Field Agent.

GHG and QWorx are in discussions regarding the development of other H-Fiber products in addition to the Field Agent project. With the legalization of hemp in the United States, Research & Development into the use of hemp biocomposites is ramping up. H-Fiber will undoubtedly be utilized as a replacement for carbon or glass fiber in a myriad of commercial applications as a result of this R&D.

In addition, GHG subsidiary, Covered Bridge Acres (“CBA”) has entered into an exclusive supply contract with Q Worx to provide all of the hemp fiber required to develop and manufacture the Field Agent. This relationship furthers GHG’s efforts to develop a “whole plant processing” model. While cannabinoids are extracted from the flowers and leaves, GHG’s Hemp Agro-Industrial Zone model was designed for whole plant processing, to not only extract cannabinoids, but to also process the straw, root and grain into additional value-added sustainable products that are higher quality and longer lasting than the petrochemical based products currently on the market.

Instagram

Follow the development of the Scio Oregon Hemp Project on Instagram @hemp_global

About Global Hemp Group Inc.
Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FRANKFURT: GHG), is focused on a multi-phased strategy to build a strong presence in the industrial hemp industry in both Canada and the United States. The Company is headquartered in Vancouver, British Columbia, with hemp cultivation operations in New Brunswick and Oregon. The first phase of this strategy is to develop hemp cultivation with the objective of extracting cannabinoids (CBD, CBG, CBN & CBC) and creating a near term revenue stream that will allow the Company to expand and develop successive phases of the strategy. The second phase of the plan will focus on the development of value-added industrial hemp products utilizing the processing of the whole hemp plant, as envisioned in the Company’s Hemp Agro-Industrial Zone (HAIZ) strategy.

[Stock Prophet]

Where does one invest? It's hard to tell in a market where you have serious companies wanting to make a business work, and a market that has a scam of selling and reversing shares bought by investors. It's frustrating at times because we all want to make money in some way, or another. But for me, I simply go by communication barriers. Even then, is all the hype legit, or bogus? Well, this company seems legit to me for one simple reason. They communicate with you! I joined their mailing list and was contacted immediately by email. Then I found this article in stockhouse! Quote: From the CEO

In conversation Stockhouse Editorial, Global Hemp Group’s President, CEO and Chairman of the Board, Charles Larsen, talked about his strong advocacy for hemp as a means to revolutionize practically every industry from medicine to food, housing, automotive, and yes, even drones.

When asked what makes his Company’s business model attractive and unique to investors, here’s what the CEO had to say:
“What really sets us apart is our experience. We already have three years of cultivation under our belt. We’ve made a lot of connections that we’ve developed into partnerships and others that will develop into partnerships and alliances – things like tissue culture.

He went on to say that to maximize profit the goal is to use 100 percent of the plant by using the fibre from the stalk, which can be used for everything from composite for the aforementioned drones to biocomposite manufacturing lines (e.g. hempcrete, bioplastic, fibre mats, insulation, etc.).
Read more at https://stockhouse.com/news/newswire/2019/06/20/taking-flight-lucrative-cbd-hemp-space#A2B1vMahFM5lASv3.99 Like I said: they communicate with you. That's a very strong connection between a company and investors. Just saying!

[Stock Prophet]

Same here! Going for 100k! Still a ways off, lol!

[BigNexEnd]

NEWS:..Planting Underway at Global Hemp Group’s Scio Oregon_Hemp_Farm...

https://www.globalhempgroup.com/06142019planting-underwayatglobal

[BigNexEnd]

NEWS: Global Hemp Group Subsidiary Contracts to have CBD Extracted from Hemp Biomass
Vancouver, BC -- (May 17, 2019) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) is very pleased to announce that its subsidiary, Covered Bridge Acres Ltd. (CBA), has entered into a contract with Richardson Gap Farm LLC (RGF) to extract cannabinoids from all of the hemp biomass produced at the Company’s Scio Oregon hemp farm. CBA is the operating company for the project, a 50/50 joint venture with Marijuana Company of America, Inc. (OTCQB: MCOA).

As previously announced, CBA has been working with a number of hemp buyers and extraction facilities in Oregon to process the Company’s biomass. RGF was one such company that ran an extraction test on the Company’s biomass, converting it to distillate (see picture below). Key reasons for choosing RGF are; supporting Oregon hemp development and the local Scio community, the excellent quality of the product they produce, as well as the proximity to the CBA farm. Working with a local company only 5.1 miles away, reduces transport costs and the associated carbon footprint, and enables CBA management to easily oversee the extraction process.

Picture1.png
The contract with RGF will process the biomass into CBD distillate. The output would then be split on a 55/45 basis, with 55% going to CBA. Based on the results from a recent test run by RGF, CBA’s 55% share of the distillate produced is expected to be 400 to 500 kg. CBA is currently selling distillate produced from earlier test extraction runs for US$4000 – US$5,000 per kg. The initial supply of biomass has been delivered to RGF and processing is expected to begin within the next 2-4 days.

In addition, RGF is currently converting 16 kg of CDB crude oil produced from the various test runs with other processors to distillate, on a 20% tolling basis. The final product is expected to be delivered to CBA earlier next week.

“While monetizing the biomass from our first hemp crop in Oregon has taken longer than we expected, we have now selected a processing partner that meets all the criteria we were looking for, with the added benefit of being one of our neighbors in Scio that is also contributing to the development of the hemp industry in the local community”, said Charles Larsen, President of Global Hemp.

CBA has also engaged H&H Wood Products (H&H) to selectively log a small hillside section of land surrounding the upper field at the Scio farm. H&H will be responsible for all logging operations, as well as transport and marketing of the logs, and CBA will be responsible for replanting the area logged. The agreement calls for CBA and H&H to share the net profit from the sale of the logs on a 50/50 basis.

In addition, the Company recently held its Annual General and Special Meeting. Management is pleased to report that all resolutions were passed by the shareholders at the Meeting.

The Board of Directors and Officers for the upcoming year will consist of:

Charles Larsen - Director, President and CEO

Curt Huber - Director, CFO and Chairman of the Audit Committee

Paul Perrault - Director and Audit Committee Member

Jeffrey Kilpatrick - Director and Audit Committee Member

The Board of Directors would like to thank all shareholders for their continued support. Proceeds from the sale of this biomass will be used to expand the operation in Scio for this coming year.

About Global Hemp Group Inc.
Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FRANKFURT: GHG), is focused on a multi-phased strategy to build a strong presence in the industrial hemp industry in both Canada and the United States. The Company is headquartered in Vancouver, British Columbia, with hemp cultivation operations in New Brunswick and Oregon. The first phase of this strategy is to develop hemp cultivation with the objective of extracting cannabinoids (CBD, CBG, CBN & CBC) and creating a near term revenue stream that will allow the Company to expand and develop successive phases of the strategy. The second phase of the plan will focus on the development of value-added industrial hemp products utilizing the processing of the whole hemp plant, as envisioned in the Company’s Hemp Agro-Industrial Zone (HAIZ) strategy.

[Daysinn4610]

Why the big drop.... is a re coming?

[BigNexEnd]

I'm Looking To Accumulate 100K Shares..Sitting.On.20K.Now...EOM

[BigNexEnd]

Global Hemp Has An Updated Website...EOM

[Daysinn4610]

Yeah i wanna know what happened too

[BigNexEnd]

Wow..Why the Share Price Tank Today?...EOM

[BigNexEnd]

FDA Sets First Hearing on CBD May 31st ...


https://www.cnbc.com/2019/04/02/fda-sets-first-hearing-on-legalizing-cannabis-compound-cbd.html

[BigNexEnd]

PR (03/28/19): PROCESSING FROM GLOBAL HEMP GROUP’S SCIO OREGON HEMP PROJECT


PROCESSING FROM GLOBAL HEMP GROUP’S SCIO OREGON HEMP PROJECT
0 COMMENTS/ MARCH 28, 2019
Vancouver, BC — (March 28, 2019) — GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG/OTC: GBHPF/FRA: GHG) and its Joint Venture partner Marijuana Company of America (OTCQB: MCOA) (together with the Company, the “Partners”) are pleased to announce that they are currently in discussions with several cannabinoid extraction companies in Oregon, USA, regarding the acquisition of the hemp biomass produced on the Scio farm from the 2018 harvest. The team at the Scio farm has prepared processing samples ranging in size from 100 lbs to 2,000 lbs. for the extraction companies. The biomass is being processed into CBD crude oil with the option to refine further into isolate or full spectrum oil to increase its value on the market. Results from the current extraction test batches are expected to be received by mid-April and will serve as basis for the final terms of the sale of the remaining biomass by the Partners.

Cloning Update
The cloning process is well underway at the Scio farm. For this year’s cultivation, four different strains have been chosen from the latest high CBD industrial hemp varieties which are being used as a base for the in-house propagation program. The goal of the program is to produce approximately 50,000 clones to populate the lower 35 acres of the Scio farm for the 2019 season and reduce and/or eliminate the need for the acquisition of any additional seeds or clones from outside sources. The program started with 400 high quality plants. Through a regimen of proper nutrients and a controlled environment, these “mother” plants will grow into very large bushes, which will then be used to take a sufficient number of clones from each mother plant to ensure that the target number of plants required for this year’s cultivation is reached. Once removed from the mother plants, the clones will then be placed in the propagation greenhouse to root. Once rooted and well established, they will be then ready to be planted in the fields, which is expected to begin this year in late May or early June.

Expansion in 2019
The Company continues to evaluate a number of opportunities to expand the scope of its project in Oregon. As previously announced, a number of local farmers are interested in working with GHG to grow hemp in 2019. The Oregon Department of Agriculture expects hemp cultivation in Oregon to grow from 11,514 acres in 2018 to more than 25,000 in this current year. In order for new hemp farmers to be successful, they will need to rely on experienced hemp farming teams like our Scio farm team. This will create potential opportunity to joint venture with the local farming community.

Micropropagation (Tissue Culture)
Management believes that the way of the future for true to type starter plants is not plants germinated from feminized seed, or clonal plants made from “mother” plants that were germinated from seed, sexually identified as female and clonally propagated by cutting, but rather through micropropagation (tissue culture) which produces plantlets with more uniformity. With ample space on the Scio farm for this type of operation, the Company is currently exploring opportunities to either Joint Venture, partner or acquire companies in this technology space.

For Further Information Contact Global Hemp Group

Charles Larsen – President

Tel: [phone]

[e-mail]

https://globalhempgroup.com

About Global Hemp Group Inc.
Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FRANKFURT: GHG), is focused on a multi-phased strategy to build a strong presence in the industrial hemp industry in both Canada and the United States. The Company is headquartered in Vancouver, British Columbia, with hemp cultivation operations in New Brunswick and Oregon. The first phase of this strategy is to develop hemp cultivation with the objective of extracting cannabinoids (CBD, CBG, CBN & CBC) and creating a near term revenue stream that will allow the Company to expand and develop successive phases of the strategy. The second phase of the plan will focus on the development of value-added industrial hemp products utilizing the processing of the whole hemp plant, as envisioned in the Company’s Hemp Agro-Industrial Zone (HAIZ) strategy.

https://globalhempgroup.com/processing-from-global-hemp-groups-scio-oregon-hemp-project/

[BigNexEnd]

$GBHPF.Volume.Is.Nearing.150%.Of.The.10.Day.Average.Volume..Volume.Is.Good.EOM

[BigNexEnd]

$GBHPF.Financials.For.1st.Q.2019.Filed.With.SEDAR.On.03.01.19...

https://www.sedar.com/GetFile.do?lang=EN&docClass=5&issuerNo=00029659&issuerType=03&projectNo=02881299&docId=4471280

[BigNexEnd]

Excellent.Politico.Article.On.The.FDA.And.CBD.Dilemma..Nice.Read...

https://www.politico.com/story/2019/03/26/marijuana-fda-food-extracts-1290835

[BigNexEnd]

$GBHPF.Filed.1st.Q.2019.Financials.On.03.01.19..MD&A.Tells.Of.Progress..

Business Update
As part of Phase One of Company’s development plan, the Company embarked on hemp cultivation in both Canada and
the United States with its Joint Venture funding partner Marijuana Company of America (the “Partners”). Nearly 160
acres of hemp was grown at the projects in 2018, employing both orchard style and field crop methods. This was the first year that both methods we employed giving the Company an opportunity to evaluate the best method of creating biomass for the extraction of cannabinoids.

SCIO, OREGON, USA ? High Yielding CBD Hemp Project
Located in the fertile Willamette Valley, approximately 70 miles south of Portland, the Company’s 109 acre Joint Venture
farm was acquired in 2018 because of a history of hemp cultivation, irrigation infrastructure with sufficient authorized
water rights to allow for irrigated cultivation, and contained a high level of organic matter in the soil, making it ideal for
hemp cultivation. The 2018 cultivation utilized the lower 33 acres of the farm and produced 48,000 pounds of dried
biomass.
The team in Scio is in the process of hammermilling the biomass prior to it being sent out for extraction of the
cannabinoids. This next level of processing will not only prepare the biomass for extraction but will also reduce the
storage space requirements by more than 50% as the bulk of the plants is reduced in size. This is the next step in
monetizing the 2018 harvest.

Preparation for the 2019 cultivation at the farm is now well underway, with the team targeting June 1st as the planting
date this year. The Company continues to evaluate ways to expand the project in the area. Discussions are underway
with local farmers who have expressed interest in partnering with the Company for the 2019 season.

NEW BRUNSWICK, CANADA Hemp Project
The Partners are developing a multi-phase hemp/CBD project on the Acadian peninsula, in northeast New Brunswick
(NB), Canada. Four farmers were contracted to grow hemp on 125 acres in the region for cannabinoid extraction in a
field cropping style. This was the second year that the hemp was grown in region, after a 20 year hiatus.
The project produced 17.5 tonnes of dried biomass from the 2018 harvest. Management anticipates significantly better
results with improved genetics and the further refinement of farming and processing practices. Industrial hemp cultivars
containing 4-5% CBD already on trial in NB would more than double the performance of current cultivars used in 2018
but have yet to be registered for use as a Health Canada approved cultivar.
Management is assessing how best to monetize the 2018 harvest. Until recently, the lack of processing infrastructure has
been a bottleneck for the entire emerging hemp industry. The change of legislation in late 2018 allowing for the extraction
of the flowers and leaves from the hemp plant has been a catalyst for investment in this type of processing infrastructure
in the industry. This is now beginning to translate into more opportunities to monetize hemp biomass going forward. The
Company is in discussions with a number of potential purchasers of the biomass at this time and is working to secure an
agreement with a processing partner.

Cash Crop Today Media, LLC
The Company holds a 50% equity interest in Cash Crop Today Media, LLC (“CCT”) (http://cashcroptoday.com). CCT
is a global media, branding, and technology company that is focused on reporting the latest industry news related to
investment information, entrepreneurship, politics, and technology from the industrial hemp and cannabis sectors. CCT
offers an array of business to business and consumer marketing services such as digital media placement and
advertising, curated video content development, management of social media campaigns, and regional, national, and
international distribution. CCT continues to develop its brand and build out its online presence.

[BigNexEnd]

Reviewed.The.2018.Year.End.Financials.And.MDA..$GBHPF.Could.Be.A.Sleeper.EOM

[whytestocks]

News: $GBHPF Marijuana Company of America Inc. (MCOA) Begins Clone Production Earlier, Aiming for Extended Growing Season

Planting at the Scio project in Oregon can begin in late May or early June, extending the growing season by 45 to 60 days The project has already received Oregon Department of Agriculture registration to cultivate hemp in 2019 Company will cultivate three different strains of hemp, char...

Read the whole news https://marketwirenews.com/news-releases/marijuana-company-of-america-inc-mcoa-begins-clone-production-earlier-aiming-for-extended-growing-season-7551720.html

[BigNexEnd]

Making.Progress..Just.Need.To.Uplist.To.OTCQB.Or.OTCQX...

CLONE PRODUCTION AT GLOBAL HEMP GROUP’S SCIO OREGON HEMP PROJECT UNDERWAY – HEMP GROWERS LICENSE RENEWED FOR 2019
JANUARY 8, 2019

https://globalhempgroup.com/clone-production-at-global-hemp-groups-scio-oregon-hemp-project-underway-hemp-growers-license-renewed-for-2019/

[Goodbuddy4863]

The Bill has passed and and president Trump signed it into law!

https://www.cannabisbusinesstimes.com/article/president-trump-signs-2018-farm-bill-legalizing-hemp/

Much less O/S here than their partner in Oregon has.

[spacevic]

Still no signature on farm bill

[PAPO813]

Forbes

https://www.google.com/amp/s/www.forbes.com/sites/andrebourque/2018/12/17/how-hemp-and-the-farm-bill-may-change-life-as-you-know-it/amp/

[Mattyalw6]

NEWS
https://www.bostonglobe.com/news/marijuana/2018/12/12/hemp-legalization-officially-headed-trump-desk-for-signature/mx5XlJHHGNWQncFga26dTK/story.html

[Mattyalw6]

This might show a 52 week high by Friday. All Trump has to do is sign bill.

[silver_bars]

Actually, they do have US operations as well...

https://globalhempgroup.com/scio-oregon/

[spacevic]

Called it!! I’ll be accepting apologies all day today, just so you know.

[Mattyalw6]

THIS THREAD IS QUIET HUH?

[Mattyalw6]

FARM BILL UP FOR VOTE TODAY

[Mattyalw6]

https://www.politico.com/story/2018/12/11/farm-bill-compromise-passage-1013284

[Mattyalw6]

WEDNESDAY FARM BILL COULD PASS.

Why are we not starting to talk about this?

https://www.politico.com/story/2018/12/11/farm-bill-compromise-passage-1013284

[Mattyalw6]

I agree with you from my own research. We may need to hang on a bit longer then anticipated; I do suggest you do your own research though.

[Mattyalw6]

In my research they have expansion plans, if not implimented, in the event of US passage. Most of the MJ sector was in Canada, or started in Canada, and expanded down.

[spacevic]

I know and that doesn’t matter. It’s US legalization that will be the catalyst for hemp. Also, the US will be the main economic importer/exporter of hemp. Think I’m wrong? Watch the stock price of Global Hemp shoot up when the farm bill is signed.

[NorthShoreTrading]

Because it's a Canadian company, and the farm bill passage is a US event.

[spacevic]

2 words. Farm bill. That’s the only thing that’s going to really move the hemp sector. If our lame ass government actually gets the thing passed, then it’s green city.

[Mattyalw6]

This seems to be the only HEMP stock not moving. I bought a measily 15K shares yesterday at .08

I expect some movement in the coming months. Thoughts?

[PotterBanker]

nope. sub .08 was the lowest imo. now more.

[greenwillow]

Gap shares?....coming, or not?